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ABSTRACT
Objective: To describe the process of developing and
validating the Canadian Association of Paediatric
Health Centres Trigger Tool (CPTT).
Methods: Five existing trigger tools were consolidated
with duplicate triggers eliminated. After a risk analysis
and modiﬁed Delphi process, the tool was reduced
from 94 to 47 triggers. Feasibility of use was tested,
reviewing 40 charts in three hospitals. For validation,
charts were randomly selected across four age groups,
half medical/half surgical diagnoses, from six
paediatric academic health sciences centres. 591
charts were reviewed by six nurses (for triggers and
adverse events (AEs)) and three physicians (for AEs
only). The incidence of trigger- and AE-positive charts
was documented, and the sensitivity and speciﬁcity of
the tool to identify charts with AEs were determined.
Identiﬁcation of AEs by nurses and physicians was
compared. The positive predictive value (PPV) of each
trigger was calculated and the ratio of false- to
true-positive AE predictors analysed for each trigger.
Results: Nurses rated the CPTT easy to use and
identiﬁed triggers in 61.1% (361/591; 95% CI 57.2 to
65.0) of patient charts; physicians identiﬁed AEs in
15.1% (89/ 591, 95% CI 0.23 to 0.43). Over a third of
patients with AEs were neonates. The sensitivity and
speciﬁcity were 0.88 and 0.44, respectively. Nurse and
physician AE assessments correlated poorly. The PPV
for each trigger ranged from 0 to 88.3%. Triggers with
a false/true-positive ratio of >0.7 were eliminated,
resulting in the ﬁnal 35-trigger CPTT.
Conclusions: The CPTT is the ﬁrst validated,
comprehensive trigger tool available to detect AEs in
children hospitalised in acute care facilities.
INTRODUCTION
International data demonstrate that the inci-
dence of adverse events (AEs) in hospitalised
adults ranges from 2.9% to 16.6%.
1e12 Physi-
ological and developmental differences in
childrencouldmakethemmorevulnerableto
harm, yet no data from methodologically
similar studies in full paediatric populations
exist. Published AE rates in children range
from0.2to154per10000dischargerecords,
13
and 1 to 2.96 per 100 discharges.
14 15 Chart
reviews targeting speciﬁc paediatric popula-
tions and speciﬁc types of AEs reveal much
higher rates.
16e18 Identifying a composite
paediatric AE rate has been hampered by
the absence of a single tool suitable for
examining AEs across paediatric populations
and events.
No single method can identify all harm
associated with patient care. Concurrent use
of complementary methods in real time and
retrospectively for AE detection has been
recommended.
19e24 Trigger tool (TT)
methodology, however, is considered the best
single tool, given its tiered approach and
sensitivity to AE detection. It can be custom-
ised to diverse settings and, used consistently,
can accurately measure harm over time.
25
The use of screening criteria to identify
charts with possible harm followed by an
in-depth review for actual harm has been
used for decades, including the landmark
Harvard Medical Practice Study.
1e11 More
recently, the Institute for Healthcare
Improvement (IHI) has recommended use
of their Global Trigger Tool (IHI-GTT)
for local quality-improvement activities.
26
Although focused paediatric TTs have been
described, there remains no TT validated to
detect AEs across all age groups of hospital-
ised children and youth.
There are growing efforts to improve
patient safety in paediatrics, and quantiﬁca-
tion of the burden of iatrogenic harm in
children could catalyse awareness and
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Original researchstimulate changes in paediatric practice and healthcare
policy, as occurred following publication of adult AE
rates. The Patient Safety Collaborative of the Canadian
Association of Paediatric Health Centres established
a working group to develop a paediatric TT (CPTT) to
detect AEs in children hospitalised in Canada.
27 The
goal was to develop a reliable and robust tool that could
be used for both local quality-improvement activities and
research into the rate, incidence, and factors contrib-
uting to AEs across a large population. The rigorous
processes used to develop, test the feasibility of use of
and validate the CPTT in detecting AEs are outlined in
this paper.
PATIENTS AND METHODS
The early development stages of the CPTT have been
previously reported.
27 Brieﬂy, ﬁve TTs identiﬁed through
a detailed literature review and personal communica-
tions were adapted to the modular format of the
IHI-GTT. The Care, Medication, Surgical and Intensive
care modules were retained, and two modules added:
Laboratory and Other. Screening criteria from all other
TTs were mapped against this list, duplicate triggers were
removed, and additional triggers recommended and
approved by consensus were added.
Each trigger in the resulting 94-trigger tool was eval-
uated for risk priority, frequency and detectability. Trig-
gers above a pre-established cut-off or mean risk score
were retained. Using a modiﬁed Delphi process, the
remaining triggers were evaluated by a team of clinical
paediatric patient safety experts who eliminated half,
resulting in the preliminary 47-trigger CPTT.
PILOT TESTING OF THE CPTT
The CPTT was piloted in three acute care paediatric
settings in Alberta: a stand-alone paediatric unit in
a community hospital, a paediatric hospital-within-a-
hospital and a regional paediatric centre. At each site,
ﬁve medical and ﬁve surgical charts were selected for
audit from ﬁscal year 2004 from each of three age
groups: 29e365 days, 366 days to 5 years and over
5 years; 10 charts were randomly selected from the
fourth age group of 0e28 days.
Two nurses visited the hospitals between June and
August 2005, and independently reviewed all 40 charts at
each hospital using the draft trigger tool. Each nurse
had undergone detailed chart abstraction training as
carried out for the Canadian Adverse Event Study,
1 and
reliability was tested using a set of standard charts.
Reviewers were asked to record any difﬁculties with
interpretation or application of trigger deﬁnitions with
particular emphasis on potential duplication or imprac-
ticality. Nurses were also asked to identify any triggers
Box 1 Six-point scale for physician determination of
causation
2
1. Virtually no evidence for management causation.
2. Slight to modest evidence for management causation.
3. Management causation not likely; less than 50/50 but
close call.
4. Management causation more likely; more than 50/50 but
close call.
5. Moderate to strong evidence for management causation.
6. Virtually certain evidence for management causation.
Table 1 Distribution of nurse and physician assessment of adverse events (AEs) as compared with the nurses’ classiﬁcation
of harm using the National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) scale
NCC-MERP
harm category Deﬁnition of category of harm
NCC-MERP AE* AE*
RN review RN review MD review
No harm No evidence of harm 442 2 34
E Temporary harm to the patient requiring intervention 80 38 22
F Temporary harm to the patient requiring initial or
prolonged hospitalisation
56 41 25
G Permanent harm 2 1 0
H Intervention required to sustain life 7 7 4
I Death 4 4 4
Total 591 93 89
For each category of harm as deﬁned by the National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP)
classiﬁcation system, we note the number of cases in that category identiﬁed as having an AE by the nurse and the physician reviewers. No
harm: nurse reviewers designated 442 cases as being in the NCC-MERP category of ‘No Harm.’ The nurses identiﬁed two, and the physician
reviewers identiﬁed 34 of the 442 cases as having had an AE. Category E: of the 80 ‘E’ category cases, 47.5% and 27.5% were designated as
an AE by the nurse and physician reviewers, respectively. Category F: of the 56 ‘F’ category cases, 73% and 46.6% were designated as an AE
by the nurse and physician reviewers, respectively. Category G: the nurse reviewers identiﬁed one of the two ‘G’ category cases as an AE,
whereas the physicians did not designate either as an AE. Category H: of the seven ‘H’ category cases, four were designated as AEs by the
nurses and physician reviewers respectively. Category I: there was complete agreement on the deaths.
*AE is deﬁned as an injury, associated with a disability and caused by healthcare management.
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Original researchthey thought should be considered for exclusion by the
Research Team. Their experience was that the tool could
be used to assess the charts, and no triggers were iden-
tiﬁed that could be eliminated. The k statistic for the
measurement of inter-rater reliability (IRR) for triggers
in 120 charts reviewed was 0.81, and the validation study
was commenced.
DEFINITIONS
Basedonthedeﬁnitionusedinpreviousnationalstudiesof
AEs, an AE was deﬁned as an unintended injury or
complication that results in disability at the time of
discharge, death, prolonged hospital stay or subsequent
hospitalisation, and is caused by healthcare manage-
ment.
1 4671 01 1The AE had to occur within a 3-month
period before or during the index admission and be
detected during or within the 3-month period before or
after the admission. ‘Healthcare management’ included
the actions of individual hospital staff, as well as the
broader systems and care processes, and included acts of
omission and commission. To qualify as an AE, healthcare
management must have received a causation rating of at
least 4 on a six-point scale, that is, greater than 50% likeli-
hood of being caused by healthcare management (box1).
The tool was validated by separate nurse and physician
reviews of the same charts of children hospitalised in six
academic paediatric health sciences centres (IWK Hospital
Halifax; Children’s Hospital of Winnipeg; Alberta Chil-
dren’s Hospital Calgary; Stollery Children’s Hospital
Edmonton; Children’s Hospital of Eastern Ontario
Ottawa; SickKids Hospital Toronto) during the ﬁscal
year 2005/2006. Validation included the use of the TT
on a sample of paediatric patient charts and the assess-
ment of those charts to determine if AEs were present.
Training for nurses and physicians
Two nurses from each of the six participating institutions,
and three physicians from the validation study team, with
at least 10 years’ academic paediatric centre experience,
attended a 2-day training session at the University of
Toronto. A customised study training manual and stan-
dard set of blinded paediatric hospital charts were used.
Following training, nurses and physicians each reviewed
20 standardised charts, and the IRR was calculated.
Data collection and IRR calculation
At each hospital, two nurses reviewed a total of 100
selected charts for evidence of triggers. Nurses deter-
mined the presence of an AE based on the presence of
an injury and harm associated with healthcare manage-
ment and then assigned a National Coordinating
Council for Medication Error Reporting and Prevention
(NCC-MERP) classiﬁcation of harm for each event
(table 1). Blinded to the nurses’ results, one of the three
physicians reviewed the same 100 charts at two sites and
classiﬁed all injuries as AEs or not, using the standard
deﬁnition of AE used in other studies (table 1). Ten per
Table 2 Characteristics and distribution of patients with adverse events (AEs)
Patient characteristics Overall
Admission age-group categories
p Level 0e28 days 29e365 days >1e5 years >5 years
Age
No of patients and
percentage of overall AEs
89 (100%) 33 (37.1%) 21 (23.6%) 17 (19.1%) 18 (20.2%) 0.006
Percentage of age group with AE 22.0% 14.2% 14.8% 10.1% ns
95th percentile CI for percentage
of age group
15.4e28.6 8.6e19.8 8.3e21.3 5.7e14.5 ns
Gender
Percentage of males with AE
(95th percentile CI)
16%
(12.4% to 20.4%)
ns
Percentage of females with AE
(95th percentile CI)
13%
(9.3% to 17.5%)
ns
In the nurses’ review, only 78 (87.6%) of the 89 AE patient charts were identiﬁed as having one or more triggers (table 3).
The sensitivity of the Canadian Association of Paediatric Health Centres Trigger Tool was 0.88 (95% CI 0.79 to 0.94) and the speciﬁcity 0.44
(95% CI 0.39 to 0.48).
Further review of the 11 (12.4%) AE charts designated by the nurses as trigger-negative revealed that the trigger: ‘Other: Any other undesirable
outcomes not covered above’ could have been applied to nine charts.
Table 3 Sensitivity and speciﬁcity of the 47-Trigger
Canadian Paediatric Trigger Tool
Trigger
Adverse event
Total Yes No
Yes 78 283 361
No 11 219 230
Total 89 502 591
Sensitivity¼0.88 (95% CI 0.79 to 0.94). Speciﬁcity¼0.44 (95% CI
0.39 to 0.48).
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Original researchTable 4 Forty-seven screening criteria of the preliminary Canadian Association of Paediatric Health Centres Trigger Tool
(CPTT)* and positive predictive values for each trigger
Care module Positive predictive value
C01 Transfusion/use of blood products 42.7
C02 Any code or arrest 62.5
C03z Unplanned admission (including readmission) as a result of any healthcare
management within the 3 months prior to or after discharge from the index
hospitalisation
26.3
C04 Infection of any kind 54.1
C05 In-hospital stroke 33.3
C06 Transfer to higher level of care 45.8
C07 Catheter inﬁltration/burn 35.3
C08x Wrong maternal breast milk nsy
C09 Complication related to central venous catheter 61.1
C10 Necrotising enterocolitis 66.7
C11 Cranial imaging in infants <3 months 38.8
C12 Extreme temperature: #35.08Co r$418C 35.5
C13 Intubation/reintubation/accidental extubation 51.5
C14 Unexpected death 80.0
C15 Emergent C-section delivery (neonate only) 40.0
C16z Unplanned admission (including readmission) as a result of any healthcare
management within the 12 months prior to the index admission
23.8
C17x Unplanned transfer to another acute care hospital (excluding transfers for tests,
procedures or specialised care not available at referring hospital)
nsy
C18x Inappropriate discharge to home/inadequate discharge plan for Index
Hospitalisation (excluding ‘against medical advice’)
20.0
C19 Dissatisfaction with care documented in the medical record and/or evidence
of complaint lodged (including documented complaint, conﬂict between
patient/family and staff, discharged against medical advice/documentation
or correspondence indicating litigation, either contemplated or actual
30.0
ICU module
I01 Readmission to ICU 33.3
I02 In-unit procedure 66.7
I03 Failed intubation 83.3
Laboratory module
L01 Abrupt drop >25% Hgb or Hct 48.8
L02x Leucopenia 18.8
Age <1 month WBC <5000/mm e3 (5.0310 e9/l)
Age 1e23 months WBC <4000/mm e3 (4.0310 e9/l)
Age 2e18 years WBC <3000/mm e3 (3.0310 e9/l)
L03 Platelet count < 50000/mm e3 (50.0310 e9/l) 55.6
L04 PTT>100 s or INR >6 66.7
L05 d-dimer (positive by local lab normal) 62.5
L06x Glucose <2.8 mmol/l (50 mg/dl) 25.0
L07 Sodium: 120 mmol/l >Na >150 mmol/l 46.2
L08 Potassium: 3.0 mmol/l >K
+ >6.0 mmol/l 35.6
L09 Rising BUN/creat >23baseline 68.5
L10 Hypoxia: O2 Sat <75% 48.1
L11 Positive blood culture 64.3
L12 Gentamicin: (except CF patients); trough >2 mg/l or peak >10 mg/l 44.0
Medication module
M01 Vitamin K (excluding newborns) 28.6
M02x Benadryl (diphenhydramine): for symptoms of allergic reaction 18.2
M03x Narcan (naloxone) 0.0
M04x Antiemetic use (for treatment of symptoms) 20.0
M05x Sodium or calcium polystyrene (kayexalate, resonium) nsy
M06 Heparin or low-molecular-weight heparin 52.4
Surgical module
S01 Unplanned or return to surgery 77.8
S02 Intraoperative intravenous epinephrine, norepinephrine, naloxone, ﬂumazenil 63.6
Continued
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Original researchcent of charts were reabstracted, and the IRR for the six
nurse teams calculated.
Validation study
Biostatistical consultation determined that 600 charts
from six paediatric healthcare centres would enable the
reliability and validity of the tool to be established with
a high degree of conﬁdence (a 0.05; b 0.10). A stand-
ardised chart selection algorithm was applied to the
Discharge Abstract Database for all paediatric separa-
tions in participating hospitals for ﬁscal 2006. One
hundred charts plus a 20% oversampling (n¼120) to
accommodate for missing charts, stratiﬁed by age group
as described above, were selected for review from those
identiﬁed by the algorithm at each site.
Charts of children receiving all levels of inpatient care
were eligible for inclusion. However, patients were
excluded if they were 18 years of age and older or their
most responsible diagnosis at discharge was obstetrical
or psychiatric. For patients with more than one hospi-
talisation during ﬁscal year 2006, one stay was randomly
selected to be reviewed for the study. No more than 100
eligible charts were reviewed at any single centre.
Analysis
Descriptive statistics were used for the trigger frequency
and the number of AEs identiﬁed. The validity of the
CPTT was judged by its sensitivity, that is, the percentage
of trigger-positive charts that physicians judged to have
an AE; and speciﬁcity, that is, the percentage trigger-
negative charts that had no AE according to physician
review. The positive predictive value (PPV) of each
trigger, and the sensitivity and speciﬁcity of the overall
tool were also determined.
Ethics
Research Ethics Board approval was obtained at each
participating centre as well as the University of
Toronto, and provincial legislation regarding privacy
and protection of evidence was respected.
RESULTS OF VALIDATION TESTING
After training for the validation study, the k statistic for
IRR for nurse-identiﬁed triggers and physician-identiﬁed
AEs was 0.62 and 0.57, respectively, and 0.67 for the IRR
for nurses at each participating site. Five hundred and
ninety-one of the 600 charts reviewed by nurses were
available for physician review; the others were misﬁled or
on the clinical wards where the patient was currently
hospitalised. Of the 591 charts reviewed by both nurses
and physicians, 361 (61.1%; 95% CI 57.2 to 65.0) had at
leastonetrigger:148(41%)hadone,145(40.2%)hadtwo,
three or four, and 59 (16.3%) had ﬁve or more triggers.
Physicians identiﬁed 340 injuries in 180 of the 591
charts. In 89 charts, the injuries met the criteria for AEs,
for an AE rate of 15.1% (95% CI 12.2% to 17.1%). The
distribution of AEs by age and gender is displayed in
table 2. Of the 89 patients with an AE, 37 (41.6%) were
designated as resulting from acts of commission, 34
(38.2%) from acts of omission and six events (6.7%)
from both; and 12 (13.5%) were not categorised.
Nurses’ assessment of harm and AEs varied by the
classiﬁcation method used, and also differed from
physicians’ assessment. MDs found AEs in 34 charts that
nurses assigned ‘No Harm’; otherwise, nurses were more
likely to identify AEs in charts at all levels of harm
severity (table 1). Nurses and physicians agreed on the
presence of an AE in 489 (82.7%) of the charts for a k of
0.34 (95% CI 0.23 to 0.43).
The PPV (table 4) and ratio of false-positive to true
positive predictors of an AE for each trigger were
calculated. The PPV ranged from 0 to 83.3. Based on
these results, and in order to improve the efﬁciency of
the CPTT, 11 triggers were removed: eight with a low
Table 4 Continued
Care module Positive predictive value
S03x Pathology report normal/unrelated 15.0
S04x Insertion of arterial or central venous line during surgery (excluding CV surgery) 25.0
S05 Removal/injury or repair of organ 40.0
S06{ Wrong site/wrong procedure/wrong patient NSy
Other module
O01 Any other undesirable outcome not covered above 31.4
All other triggers were retained in the ﬁnal 35-trigger CPTT.
*The positive predictive value and ultimate disposition of each trigger are also shown.
yScreening criterion (trigger) was never selected by nurse reviewers in this sample of 600 cases.
zScreening criterion C16 merged with C03.
xScreening criterion (trigger) with low positive predictive value or not selected removed from CPTT.
{Wrongsite/wrongprocedure/wrongpatientcriterion:arareeventbutalwaysassociatedwithanAEandthereforeretaineddespiteNSdesignation.
ICU, intensive care unit; Hgb, haemoglobin; Hct, haematocrit; WBC, While blood count; PTT, partial thromboplastin time; INR, international
normalised ratio; BUN, blood urea nitrogen; creat, creatinine; CF, cystic ﬁbrosis; CV, cardiovascular.
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never selected. A fourth unselected trigger, ‘wrong site
surgery,’ was retained, and the two readmission triggers
merged (C03 and C16). These revisions resulted in the
ﬁnal 35-trigger CPTT (table 5).
DISCUSSION
Several agencies, including the Agency for Healthcare
Research and Quality, have argued that indicators
needed to be developed for speciﬁc populations,
including paediatrics.
28 We concluded that a robust TT,
validated for paediatric use, was necessary for evaluating
AEs and conducting a national paediatric study in
Canada. Unlike the IHI-GTT where individual modules
were validated separately, the CPTT has been validated
for use as a single tool for all paediatric populations.
Similar to the other national studies of AEs, use of our
tool calls for a two-stage review process: ﬁrst, nurses use
the trigger tool to identify charts likely to have an AE,
followed by physicians who review the triggered charts
for AEs. However, in order to establish the sensitivity of
Table 5 35-Trigger Canadian Paediatric Trigger Tool
Care module
C 01 Transfusion/use of blood products
C 02 Any code or arrest (successfully resuscitated)
C 03 Unplanned admission (including readmission) as a result of any healthcare management within the 3 months
prior to OR after discharge from the index hospitalisation
C 04 Infection of any kind
C 05 In hospital stroke
C 06 Transfer to higher level of care
C 07 Catheter inﬁltration/burn
C 08 Complication related to central venous catheter
C 09 Necrotising enterocolitis
C 10 Cranial imaging in infants #3 months
C 11 Extreme temperature: $358C (358C) or #408C (408C)
C 12 Intubation/reintubation/accidental extubation
C 13 Emergent C-section delivery (neonate only)
C 14 Dissatisfaction with care documented in the medical record and/or evidence of complaint lodged (including
documented complaint, conﬂict between patient/family and staff, discharged against medical advice/
documentation or correspondence indicating litigation, either contemplated or actual
C 15 Unexpected death
ICU module
I 01 Readmission to ICU
I 02 In-unit procedure
I 03 Failed extubation
Laboratory module
L 01 Abrupt drop $25% Hgb or Hct
L 02 Platelet count < 50000/mm
3 (50310 e9 l)
L 03 PTT>100 s or INR>6
L 04 D-dimer (positive by local lab normal)
L 05 Sodium: 120 mmol/l>Na>150 mmol/l
L 06 Potassium: 3.0 mmol/l>K
+>6.0 mmol/l
L 07 Rising BUN/creat >23baseline
L 08 Hypoxia: O2 Sat <75%
L 09 Positive blood culture
L 10 Gentamicin/tobramycin: (except CF patients) trough <2 mg/l or peak >10 mg/l
Medication module
M 01 Vitamin K (excluding newborns)
M 02 Heparin or low-molecular-weight heparin
Surgical module
S 01 Unplanned or return to surgery
S 02 Intraoperative intravenous epinephrine, norepinephrine, naloxone, ﬂumazenil
S 03 Removal/injury or repair of organ
S 04 Wrong site/wrong procedure/wrong patient
Other module
O1 Other/any other undesirable outcomes not covered above
ICU, intensive care unit; Hgb, haemoglobin; Hct, haematocrit; WBC, While blood count; PTT, partial thromboplastin time; INR, international
normalised ratio; BUN, blood urea nitrogen; creat, creatinine; CF, cystic ﬁbrosis; CV, cardiovascular.
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independently for triggers (by nurses) and for AEs (by
physicians and nurses). This process is the ﬁrst of its
kind to establish a false-negative rate for triggered
charts, by identifying patients with AEs whose charts
were not triggered. The number of false-negative charts
may be reduced through education highlighting use
of the ‘other’ trigger by the nurses. Nurse and physician
review of all charts for AEs also demonstrated differences
between these groups in designating AEs. Nurses
and physicians assessed the charts using somewhat
different methods. Nurses reviewed charts using the
CPTT and assessed all charts in terms of the NCC-MERP
Harm Scale and the presence of AEs,
29 whereas physi-
cians reviewed all charts for AEs only. These different
methods mean their results are not strictly comparable.
However, the physicians read each case from admission
to discharge, and based on these ﬁndings, it appears
that physicians may be better qualiﬁed to assess the
presence of AEs. This difference between nurse and
physician assessment of AEs is consistent with previous
ﬁndings,
30 31 but these ﬁndings should be explored
further.
There are inherent limitations in TT methodology. The
utility of any chart review is subject to the quality of the
documentation.
32 Like other screening tests, TTs have
a high sensitivity and relatively low speciﬁcity. However,
theirpurposeistocullchartsunlikelytohaveanAE,leaving
behind for physician review only those charts with a high
probability of having an AE. The IRR of identifying AEs
through chart review is variable; previous studies reported
k scores ranging from  0.077 to 0.66.
1e91 61 93 2 e35
Combining ratings from more than one physician
19 36and
monitoring reviewer performance during the study with
personal feedback may improve IRR.
30 However, a recent
report suggests that a review process involving two
physicians per chart is no more reliable than only one in
detecting AEs.
36 Additional training that includes
aconsensusapproachonthenumberofAEsinthetraining
charts has been used successfully.
35 Finally, previous
nationalstudiesofAEshavefocusedonthosecharacterised
by signiﬁcant harm, that is NCC-MERP categories FeI,
underestimating the total burden of harm by disregarding
events with temporary harm requiring intervention only
(category E events). Although achieving high IRR for
category E can be challenging,
35 capturing these events in
future studies will result in a more comprehensive view of
the nature of iatrogenic injury, and permit comparisons
with recent studies of AEs in children and youth that have
used the expanded deﬁnition.
17 18
Despite these limitations, the use of a broad paediatric
population sample to validate the CPTT permits its use
in other acute care paediatric institutions. With its ﬁnal
reﬁnements, the validated CPTT offers the ﬁrst
comprehensive evidence-based tool for assessing harm in
hospitalised children and youth.
CONCLUSION
The CPTT is the ﬁrst valid and reliable TT for detecting
harm in children and youth of all ages hospitalised in
acute care. This 35-trigger tool is reliable and robust, and
can be used in quality-improvement initiatives and for
more rigorous research agendas.
Future research should focus on improving the efﬁ-
ciency of the CPTT and investigating the differences
between nurse and physician assessments of AEs. The
CPTT is likely to be of interest to researchers wishing to
comprehensively study the epidemiology and burden of
iatrogenic harm in hospitalised children and youth,
using a methodology similar to the previous national
studies of AEs in hospitalised adults. Such studies will
enhance current efforts to raise the proﬁle of paediatric
patient safety issues.
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